Question 1

What is the catalog number for Porcine very late appearing antigen 4, VLA4 ELISA Kit?

Accepted Answer

The catalog number for Porcine very late appearing antigen 4, VLA4 ELISA Kit is YLA0239PO.

Question 2

What sizes are available for Porcine very late appearing antigen 4, VLA4 ELISA Kit?

Accepted Answer

Porcine very late appearing antigen 4, VLA4 ELISA Kit is available in the following size(s): 48 Tests, 96 Tests.

Question 3

How many pack sizes does Porcine very late appearing antigen 4, VLA4 ELISA Kit come in?

Accepted Answer

Porcine very late appearing antigen 4, VLA4 ELISA Kit is available in 2 different pack sizes.

Question 4

Is Porcine very late appearing antigen 4, VLA4 ELISA Kit in stock?

Accepted Answer

Porcine very late appearing antigen 4, VLA4 ELISA Kit is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 7

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Porcine very late appearing antigen 4, VLA4 ELISA Kit

Product Specifications

CAS Number

Shelf Life

Available Sizes

Frequently Asked Questions

Explore Other Products

Anti-IGFBP1 Antibody Picoband®

Desmoglein-3 (Squamous Cell Marker) (DSG3/2837), Biotin conjugate, 0.1mg/mL

Anti-TCEB2/Elongin-B/ELOB Antibody Picoband®, Carrier-free

CD11b / MAC-1 (Microglial Marker) (ITGAM/3338), CF740 conjugate, 0.1mg/mL

CD1a (C1A/711), CF568 conjugate, 0.1mg/mL

CD73 (Immuno-Oncology Target) (NT5E/2505), 0.2mg/mL